ResMed Cash Flow Overview
| RMD Stock | USD 177.61 3.78 2.17% |
ResMed |
Most accounts from ResMed's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ResMed Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out ResMed Valuation and ResMed Correlation analysis. At present, ResMed's Begin Period Cash Flow is projected to decrease significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 238.6 M, whereas Change In Cash is projected to grow to (39.2 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Dividends Paid | 245.3M | 258.3M | 297.0M | 195.3M | Stock Based Compensation | 65.3M | 71.1M | 81.8M | 85.9M |
ResMed cash flow statement Correlations
Click cells to compare fundamentals
ResMed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ResMed cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (69.9M) | (22.0M) | (311.7M) | (248.8M) | (223.9M) | (212.8M) | |
| Change In Cash | 316.0M | (167.9M) | (21.6M) | (45.8M) | (41.2M) | (39.2M) | |
| Free Cash Flow | 696.3M | 619.9M | 195.1M | 559.3M | 643.2M | 675.4M | |
| Depreciation | 181.4M | 191.5M | 193.8M | 197.6M | 227.2M | 238.6M | |
| Other Non Cash Items | (7K) | 8.7M | 20.7M | (11.1M) | (9.9M) | (9.4M) | |
| Capital Expenditures | 105.9M | 116.8M | 156.0M | 134M | 154.1M | 161.8M | |
| Net Income | 621.7M | 474.5M | 779.4M | 897.6M | 1.0B | 1.1B | |
| End Period Cash Flow | 463.2M | 295.3M | 273.7M | 227.9M | 262.1M | 336.6M | |
| Dividends Paid | 225.1M | 226.7M | 245.3M | 258.3M | 297.0M | 195.3M | |
| Change To Netincome | 82.6M | 69.3M | 85.9M | 60.3M | 69.4M | 45.6M | |
| Investments | (46.0M) | (158.5M) | (13.9M) | (1.2B) | (1.0B) | (991.7M) | |
| Net Borrowings | (94.0M) | (522M) | 122M | 665M | 764.8M | 803.0M |
Currently Active Assets on Macroaxis
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out ResMed Valuation and ResMed Correlation analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 1.84 | Earnings Share 6.04 | Revenue Per Share 30.633 | Quarterly Revenue Growth 0.125 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.